Delivery Order SPE2DB20D3304-SPE2DB25FW6J7

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a firm fixed price of $1,249.44 and a completion date of June 27, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication. The contract has a firm fixed price of $2,945.89 and a period of performance through April 17, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,029.07, is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products. The contract is a firm fixed-price, non-set-aside, with a completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product. The contract has a ceiling value of $21,489.45 and a period of performance ending on June 24, 2025. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $13,017.94 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a prescription medication, with a period of performance through May 29, 2025. The contract has a Firm Fixed Price pricing structure and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a $1,841.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a prescription medication, with a performance period through April 15, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,852.01, is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medication used to treat respiratory conditions. The contract is a firm fixed-price, non-set-aside award with a completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a type of medication, with a ceiling value of $1,784.98. The contract is a firm fixed price, non-set-aside award with a period of performance through June 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 115-21 12GM, a medication used to treat respiratory conditions. The firm-fixed-price contract has a ceiling value of $2,654.88 and a period of performance through June 27, 2025. The contract is not designated as a set-aside and is considered an open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a ceiling value of $1,543.62. The contract is a firm fixed price delivery order with a completion date of June 16, 2025. This contract is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime contractor and...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW6J7
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,406.25, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a prescription medication. The contract is a firm fixed price delivery order and is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/21/25, 7:42 PM